Tomer Berkovitz

Tomer Berkovitz has been working in various roles since 2002. Tomer began their career as a Lecturer and Academic Coordinator at Tel Aviv University - Coller School of Management. Tomer then moved to Citi as a Consultant in Investment Banking in 2005. From 2008 to 2014, Tomer worked at JPMorgan in various roles, including Executive Director, Vice President, and Associate in Investment Banking. In 2014, they became COO and CFO at Alcobra. In 2018, Tomer joined aMoon Fund as a General Partner and also became a Board Member and Lead Investor for Zebra Medical Vision Ltd. In 2019, they became a Board Observer and Lead Investor for Seer. In 2020, Tomer was appointed as a Board Member and Lead Investor for both SOPHiA GENETICS and PrognomiQ Inc. Finally, in 2021 they became a Board Observer and Investor for Omada Health.

Tomer Berkovitz has a Ph.D. in Finance from Columbia Business School with Distinction, an M.Sc. in Finance and Accounting from Tel Aviv University - Coller School of Management Magna Cum Laude, and a B.A. in Economics and Management from Tel Aviv University Magna Cum Laude.